Antitumor activity and safety of sirolimus for solid tumors with PIK3CA mutations: A multicenter, open-label, prospective single-arm study (KM 02-01, KCSG UN17-16)
Byeon, Seonggyu, Kang, Myoung Joo, Choi, Yoon Ji, Kim, Yu Jung, Kim, Miso, Yun, Jina, Yi, Seong Yoon, Kim, Jin Young, Kim, Seung Tae, Lee, JeeyunVolume:
9
Journal:
Translational Cancer Research
DOI:
10.21037/tcr.2020.04.07
Date:
May, 2020
Fichier:
PDF, 504 KB
2020
File converter
Plus de résultats de recherche
More benefits 
